Clinical Restaging and Tumor Sequencing Are Not Indicators of Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Restaging and Tumor Sequencing Are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Eur Urol 2020 Aug 17;[EPub Ahead of Print], REN Becker, AR Meyer, A Brant, AC Reese, MJ Biles, KT Harris, G Netto, A Matoso, J Hoffman-Censits, NM Hahn, W Choi, D McConkey, PM Pierorazio, MH Johnson, MP Schoenberg, MR Kates, A Baras, TJ BivalacquaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.